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1,2,4-Triazole system is a structural element of many drugs that have antimycotic
activity such as fluconazol, itraconazol, voriconazol (1, 2). One of the methods of prepar-
ing derivatives of 1,2,4-triazole is the cyclization reaction of acyl derivatives of thiosemi-
carbazide in alkaline medium (3–13). Using the cyclization reactions of thiosemicarbazi-
de derivatives of 1,2,4-triazole-1-acetic acid and 1,2,4-triazole-4-acetic acid compounds
composed of two 1,2,4-triazole systems connected by a methylene group were prepared
(3, 4).
As a continuation of investigations of compounds of a similar structure, a series of
new 1,2,4-triazoline-5-thione derivatives with potential pharmacological activity on the
central nervous system were prepared (14). When investigated on mice, these com-
pounds did not produce neurotoxic activity, but acted on the central nervous system cal-
matively, and prolonged the hexobarbital sleeping time significantly and depressed the
locomotor activity (14). Derivatives of 1,2,4-triazoline-5-thione show different biological
activities: analgesis (15), antiinflamatory (16), bacteriostatic (17, 18), antifungal (19).
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In the reaction of hydrazide of thiophene-2-acetic acid
(1) with isothiocyanates, the respective thiosemicarba-
zides 2a-g were obtained. Further cyclization with 2%
NaOH led to formation of 4-substituted-3-(thiophene-
2-yl-methyl)-2-1,2,4-triazoline-5-thiones (3a-g). These
compounds showed promising antimycotic activity.
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This work is a continuation of our search for 1,2,4-triazole derivatives with antimy-
cotic and antibacterial activity.
EXPERIMENTAL
Melting points were determined in Fisher-Johns blocs (Sanyo, Japan) and are pre-
sented without corrections. IR spectra were recorded in KBr using a Specord IR-75 spec-
trophotometer (Perkin Elmer, UK). The 1H NMR spectra were recorded on a Bruker
Avance 300 (Bruker, Germany) in DMSO-d6 with TMS as internal standard.
Chemicals were purchased from Merck (Germany) or Fluka (Switzerland) and were
used without purification. Purity of all compounds was checked by TLC on aluminium
oxide 60 F254 plates (Merck), in a CHCl3/C2H5OH (10:2) solvent system with UV visuali-
zation ( = 254 nm).
Syntheses
Thiophene-2-acetic acid hydrazide (1). – Ethyl thiophene-2-acetate (0.01 mol, 1.7 g), dry
ethanol (5 mL) and hydrazine hydrate (0.02 mol) were boiled for 3 h under reflux. After
cooling, the precipitate was filtered off, dried and recrystallized from 95% ethanol. m.p.
89–90 °C; Yield 1.28 g (89%). Analysis for C5H8N2OS (Mr 144.31): calcd. C 41.65%, H
5.59%, N 19.43%; found: C 41.52%, H 5.09%, N 19.37%. Spectral data were as follows: IR
(max): 3240 (NH), 3047 (CH arom.), 1427 (CH aliph.), 1678 (C=O) cm–1.
1H NMR ( ppm): 3.57 (s, 2H, CH2), 4.28 (s, 2H, NH2), 6.89–6.95 (m, 2H, 2CH), 7.32–
7.34 (m, 1H, CH), 9.23 (s, 1H, NH).
Thiosemicarbazide derivatives of thiophene-2-acetic acids (2a-g). – Hydrazide 1 (0.01 mol)
and isothiocyanates (0.01 mol) were mixed carefully and then placed in a round-bottom
flask, and heated on oil bath at 90 °C for 10 h. The reaction product was washed with di-
ethyl ether in order to remove the unreacted isothiocyanate and then with water to re-
move unreacted hydrazide. Next, the product was filtered, dried and crystallized from
95% ethanol.
4-Substituted-3-(thiophene-2-yl-methyl)-2-1,2,4-triazoline-5-thiones (3a-g). – Thiosemi-
carbazide 2a-g (0.01 mol) and sodium hydroxide (2%, 40 mL) were boiled for 2 h. After
cooling, the solution was neutralized with diluted hydrochloric acid. The precipitate
was filtered off and then crystallized from 95% ethanol.
The data relating to compounds 2a-g and 3a-g are listed in Table I.
Microbiological tests
Compounds 2a, 2c-e, 3a and 3c-e were assayed for their antimicrobial activity in vi-
tro against 11 strains of aerobic bacteria – 3 strains of Gram-positive bacteria (Staphylo-
coccus aureus, Staphylococcus epidermidis, Enterococcus faecalis), 8 strains of Gram-negative
bacteria (Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Proteus mirabilis, Salmonel-
la enteritidis, Salmonella agonae, Yersinia enterocolitica, Pseudomonas aeruginosa) and 12
252
M. Wujec et al.: Synthesis and potential antimycotic activity of 4-substituted-3-(thiophene-2-yl-methyl)-2-1,2,4-triazoline-5-thiones,
















































































































2971, 1432 (CH aliph.)
1695 (C=O)
1375 (C=S)
1.03–1.08 (t, 3H, CH3) J = 7.1 Hz
3.41–3.48 (q, 2H, CH2) J = 6.9 Hz
3.68 (s, 2H, CH2)
6.88–6.97 (m, 2H, 2CH)
7.36–7.38 (m, 1H, CH)














2931, 1423 (CH aliph.)
1690 (C=O)
1342 (C=S)
3.72 (s, 2H, CH2)
4.73 (s, 2H, CH2)
6.94–6.97 (m, 2H, 2CH)
7.22–7.31 (m, 5H, arom. benz.)
7.33–7.38 (m, 1H, CH)














2921, 1496 (CH aliph.)
1687 (C=O)
1358 (C=S)
3.76 (s, 2H, CH2)
6.94–6.97 (m, 2H, 2CH)
7.14–7.19 (m, 1H, CH)
7.31–7.44 (m, 5H, arom. benz.)
9.63 (s, 2H, 2NH)














2956, 1406 (CH aliph.)
1680 (C=O)
1336 (C=S)
2.28 (s, 3H, CH3)
3.75 (s, 2H, CH2)
6.93–6.97 (m, 2H, 2CH)
7.12–7.36 (m, 4H, arom. benz.)
7.37–7.39 (m, 1H, CH)
9.56 (s, 2H, 2NH)

















































































































2958, 1435 (CH aliph.)
1668 (C=O)
1336 (C=S)
3.32 (s, 3H, CH3)
3.75 (s, 2H, CH2)
6.88–6.93 (m, 2H, 2CH)
6.95–7.27 (m, 4H, arom. benz.)
7.37–7.39 (m, 1H, CH)
9.52 (s, 2H, 2NH)

















3.77 (s, 2H, CH2)
6.94–6.98 (m, 2H, 2CH)
7.35–7.51 (m, 4H, arom. benz.)
7.53–7.54 (m, 1H, CH)
9.74 (s, 2H, 2NH)

















3.78 (s, 2H, CH2)
6.94–6.98 (m, 2H, 2CH)
7.32–7.37, 7.47–7.50 (m, 4H,
arom. benz.)
7.38–7.41 (m, 1H, CH)
9.73 (s, 2H, 2NH)

















0.97–1.02 (t, 3H, CH3) J = 7.1 Hz
3.89–3.96 (q, 2H, CH2) J = 7.1 Hz
4.37 (s, 2H, CH2)
6.98–7.05 (m, 2H, 2CH)
7.44–7.46 (m, 1H, CH)

















4.17 (s, 2H, CH2)
5.23 (s, 2H, CH2)
6.81–6.82 (m, 1H, CH)
6.87–6.89, 7.30–7.37 (m, 5H,
arom. benz.)
7.18–7.21 (m, 2H, 2CH)





































































































4.10 (s, 2H, CH2)
6.57–6.58 (m, 1H, CH)
6.82–6.85, 7.30–7.52 (m, 5H,
arom. benz.)
7.27–7.29 (m, 2H, 2CH)

















2.37 (s, 3H, CH3)
4.07 (s, 2H, CH2)
6.61–6.63 (m, 1H, CH)
6.85–6.87, 7.30–7.40 (m, 4H,
arom. benz.)
7.14–7.17 (m, 2H, 2CH)

















3.81 (s, 3H, CH3)
4.05 (s, 2H, CH2)
6.81–6.82 (m, 1H, CH)
6.87–6.89, 7.30–7.37 (m, 4H,
arom. benz.)
7.18–7.21 (m, 2H, 2CH)

















3.77 (s, 2H, CH2)
6.63–6.65 (m, 1H, CH)
6.84–6.87 (m, 1H, CH)
7.25–7.30, 7.69–7.74 (m, 4H,
arom. benz.)
7.34–7.36 (m, 1H, CH)

















4.13 (s, 2H, CH2)
6.63–6.64 (m, 1H, CH)
6.84–7.59 (m, 4H, arom. benz.)
7.50–7.59 (m, 2H, 2CH)
13.89 (s, 1H, NH)
strains of fungi – yeast-like fungi (Candida albicans, Candida famata, Geotrichum candidum),
moulds (Aspergillus fumigatus, Aspergillus niger, Penicillium spp., Scopulariopsis spp.) and
dermatophytes (Trichophyton granulosum, Trichophyton galinae, Trichophyton interdigitale,
Trichophyton mentagrophytes, Trichophyton rubrum). Tested microorganisms were isolated
from clinical specimens. In addition, two reference strains of dermatophytes – Trichophy-
ton mentagrophytes ATCC9533 and Trichophyton rubrum ATCC28188 were included in the
studies.
The minimal inhibitory concentration (MIC) defined as the lowest concentration of
the compound preventing visible growth, was estimated for all compounds, by agar di-
lution method, using Mueller-Hinton medium without or with 4% glucose for the
growth of bacteria and fungi, respectively (20).
The compounds were dissolved in mixture of acetone and DMSO (1:1). The final
concentration of each solvent in the medium (2%) had no influence on the growth of
tested microorganisms. Microbial cultures (optical density of 0.5 McFarland standard,
0.025 mL) were put into Petri dishes with 20 mL medium containing several concentra-
tions of the compounds (500, 250, 125, 62.5, 31.25 mg L–1). The media were incubated for
18 h at 37 °C for bacteria or for 5 days at 30 °C for fungi. The medium with no synthe-
sized compounds added served as the control.
RESULTS AND DISCUSSION
Hydrazide of thiophene-2-acetate (1) was obtained in the reaction of ethyl thiophe-
ne-2-acetate with hydrazine hydrate. The new thiosemicarbazide derivatives (2) were
obtained in the reaction of hydrazide with isothiocyanates. These compounds were sub-
jected to cyclization in a 2% solution of sodium hydroxide, giving suitable, 4-substitu-
ted-3-(thiophene-2-yl-methyl)-2-1,2,4-triazoline-5-thiones (3). The reaction was perfor-
med according to Scheme 1.
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R = C2H5, CH2C6H5, C6H5, 4-CH3-C6H4, 4-OCH3-C6H4, 4-BrC6H4, 4-Cl-C6H4
Scheme 1
The structure of the new compounds was confirmed by elemental analysis as well
as the IR and 1H NMR spectra. 1H NMR spectra of thiosemicarbazide derivatives (2)
gave proton signals typical of the NH group in the range  (ppm) 7.93–10.21. In 1H NMR
spectra of 4-substituted-3-(thiophene-2-yl-methyl)-2-1,2,4-triazoline-5-thiones (3), pro-
ton signals for –NH group in the  (ppm) 13.62–13.89 range were observed. The above
observations suggest that the compounds exist mainly in the thione form.
According to the results from Table II, none of the compounds tested (2a, 2c-e, 3a,
3c-e) inhibited the growth of Gram-positive and Gram-negative bacterial strains, not
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Table II. Antibacterial activity of the tested compounds
Species
MIC (mg L–1)

































































































a Growth inhibition by about 50–70% at a concentration of 500 mg L–1 compared to growth intensity on the
medium without the tested compound (visual assessment).
b Growth inhibition by about 80–90% at a concentration of 125, 250 or 500 mg L–1 compared to growth inten-
sity on the medium without the tested compound (visual assessment).
even at a concentration > 500 mg L–1. However, compounds 2d, 3c, 3d affected the
growth of some Staphylococci by about 50–70%.
As shown in Table II, none of the compounds except compound 2d, inhibits the
growth of yeast-like fungi and moulds even at a high concentration of 500 mg L–1. Only
compound 2d affected the growth of Aspergillus niger by 50–70% at 500 mg L–1.
Likewise, compounds 2a, 2c and 3c showed no inhibitory effect on the growth of
dermatophytes (MIC > 500 mg L–1). In contrast, compounds 2d, 2e, 3a, 3d, 3e showed to-
tal or partial inhibitory effect on the growth of some clinical and reference species of Tri-
chophyton spp. at concentrations of 250 or 500 mg L–1. Besides, some of them affected the
growth of dermatophytes by 80–90% at a concentration of 125 mg L–1. It is worth noting
that even MICs of some triazoles currently used in the treatment of mycoses, including
dermatophytoses, showed high variability in activity against different species of Tricho-
phyton (e.g., for itraconazole MIC range from 0.015 to 8 mg L–1, for fluconazole from 0.5
to 64 mg L–1).
CONCLUSIONS
In this report, an easy method of synthesizing 4-substituted-3-(thiophene-2-yl-me-
thyl)-2-1,2,4-triazoline-5-thione in good yield is presented. Eight new compounds were
tested for their antibacterial and antifungal activity. Our preliminary data indicate that
the assessed, newly synthesized compounds had no significant antibacterial activity but
some of them (compounds 2d, 2e, 3a, 3d, 3e) showed promising antifungal activity
against some species belonging to Trichophyton spp. known as the causative agents of su-
perficial mycoses. The most effective derivatives have the carbon ring substituted with a
methyl or methoxy group. Although MICs values for the newly synthesized compounds
were higher than those for currently available triazoles (e.g., fluconazole, itraconazole),
we found them as a good basis for further research.
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S A @ E T A K
Sinteza i antimikotsko djelovanje 4-supstituiranih
3-(tiofen-2-il-metil)-2-1,2,4-triazolin-5-tiona
MONIKA WUJEC, MONIKA PITUCHA, MARIA DOBOSZ, URSZULA KOSIKOWSKA i ANNA MALM
Rekacijom hidrazida tiofen-2-octene kiseline (1) s izotiocijanatima sintetizirani su
odgovaraju}i tiosemikarbazidi (2a-g), a njihovom ciklizacijom u 2% NaOH 4-supstitui-
rani 3-(tiofen-2-il-metil)-2-1,2,4-triazolin-5-tioni (3a-g). Sintetizirani spojevi su potenci-
jalni antimikotici.
Klju~ne rije~i: 4-supstituirani 3-(tiofen-2-il-metil)-2-1,2,4-triazolin-5-tioni, sinteza, spektralna anali-
za, antimikotsko djelovanje
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